Clarify rationale behind COVID-19 vaccine pricing; Consider invoking Patent Act: SC tells Centre

India

oi-Deepika S

|

New Delhi, Apr 27: Amid the controversy over the price uniformity of the COVID-19 vaccine in India, the Supreme Court on Tuesday ordered the Central government to clarify the basis and rationale on which vaccines are being priced in the country.

The SC Bench of Justices DR Chandrachud and Justices L Nageswara Rao and Ravindra Bhat was hearing a suo motu cases registered in the wake of the COVID crisis in the country.

SC on Vaccine pricing in India

Then bench noted that different vaccine manufacturers were quoting different prices for their vaccines at a time when the country is passing through national crisis.

The apex court, orally urged the Central government to examine the necessity of invoking provisions under the Patent Act to regulate prices of COVID vaccines if necessary.

“Regarding pricing on vaccination different manufacturers is quoting in different…

Exit mobile version